series-c-plus
Stage
2016
Founded
4
Investors
About
Orca Bio is a clinical-stage biotechnology company developing allogeneic cell therapy products intended to replace diseased blood and immune systems. The company builds a manufacturing platform that sorts donor blood at single-cell precision to produce therapeutic mixtures of immune and stem cells.
Explore Orca Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.